SKI Market

A+| A| A-|

Indian Indices

Sensex

76,922.64 443.97
( 0.58%)

Global Indices

Nasdaq

52,316.93 113.19
(0.22%)

Dow Jones

7,516.83 55.40
(0.74%)

Hang Seng

70,577.01 514.69
(0.73%)

Nikkei 225

10,511.26 27.04
(0.26%)

Forex

USD-INR

94.49 0.37
(0.39%)

EUR-INR

107.78 0.64
(0.60%)

GBP-INR

125.01 0.85
(0.69%)

JPY-INR

0.58 0.00
(0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

65.59

174618.6

EPS(TTM)

Face Value()

Div & Yield %

100.29

0.46

Back

Board of Shriram Finance recommends final dividend

Apr 24,2026

Shriram Finance announced that the Board of Directors of the Company at its meeting held on 24 April 2026, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 300%) , subject to the approval of the shareholders.

76,922.64 443.97 ( 0.58%)

52,316.93 113.19 (0.22%)

7,516.83 55.40 (0.74%)

70,577.01 514.69 (0.73%)

10,511.26 27.04 (0.26%)

94.49 0.37 (0.39%)

107.78 0.64 (0.60%)

125.01 0.85 (0.69%)

0.58 0.00 (0.33%)